Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × ASP3662 × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Diabetes Mellitus, Type 2 1 Cushing Syndrome 1 ACTH Syndrome, Ectopic 1

Interventions

Specimen Handling 428 pembrolizumab 422 Magnetic Resonance Spectroscopy 370 Carboplatin 302 Cyclophosphamide 270 Cisplatin 255 Biopsy 237 Radiotherapy 213 Paclitaxel 199 Gemcitabine 199 Bevacizumab 186 Nivolumab 170 venetoclax 166 fludarabine 156 Drug Therapy 145 Blood Specimen Collection 144 Dexamethasone 140 Docetaxel 135 Oxaliplatin 134 Injections 134 Capecitabine 133 Fluorouracil 132 Radiosurgery 122 Rituximab 121 Standard of Care 119 Pemetrexed 114 atezolizumab 105 durvalumab 100 Radiation 100 Doxorubicin 97

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07296484 2026-02-12

CAPTAIN-T2D

Sparrow Pharmaceuticals

Phase 2 Recruiting

ACTH Syndrome, Ectopic, Cushing Syndrome, Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡